This paper describes the case of a malignant retroperitoneal paraganglioma with extensive metastases. The patient presented with a supraclavicular mass and an absence of hypertension.
Introduction
Catecholamine producing tumours may arise within the adrenal medulla or at sites of paraganglionic tissue including the carotid body, glomus jugulare, vagus nerve, mediastinum, retroperitoneum and bladder.' There are no consistently reliable histological or biochemical features to distinguish benign from malignant tumours of this type. 2 The presence of raised dopamine metabolites may, however, be a marker of malignancy as has been described for adrenal phaeochromocytoma3 and in a previous case of paraganglioma. 4 The present case illustrates the occurrence of exclusively raised dopamine metabolites in a case of malignant retroperitoneal paraganglioma with a notable absence of hypertension.
Case report
A 26 year old male presented with a mass in the left supraclavicular fossa and increasing dyspnoea. He had been unwell for a period of 18 months although he had not previously sought medical advice. On examination he was frail, anaemic and dyspnoeic with a large left sided neck mass and bilateral pleural effusions. Blood pressure was 150/60 mmHg and it is noteworthy that he remained consistently normotensive throughout the course of his illness. There was hepatomegaly and an irregular 10 cm central abdominal mass. The initial clinical impression was of a disseminated lymphoreticular malignancy although no other lymph node groups were enlarged. Chest X-ray confirmed bilateral pleural effusions. A total of 2 litres of exudate was aspirated from the left pleural cavity and found to contain lymphocytes and reactive mesothelial cells but no malignant cells. Abdominal ultrasound revealed a huge mass of tissue, probably para-aortic nodes, extending to the left and surrounding a distorted, hydronephrotic left kidney. A computerized tomographic (CT) scan of the abdomen demonstrated a large mass of lymph nodes extending from the retrocrural area with a maximum diameter of 15 -20 cm involving the lesser omentum, surrounding the pancreatic, para-aortic and paracaval areas and extending to the pelvic brim. There were also deposits in both the right and left lobes of the liver and evidence of bilateral common iliac lymphadenopathy.
Haematological investigations showed a haemoglobin of 9.6 g/dl, a normochromic normocytic blood film and an ESR of 31. Urea and electrolytes were normal. The alkaline phosphatase was raised at 2,240 IU/I (reference range 100-350) and also alanine transaminase at 113 IU/I (reference range 5-40) but with a normal bilirubin.
Surgical biopsy of the neck mass was performed. Histological examination showed a well defined nodule of tumour tissue with a pronounced alveolar pattern, interspersed with fibrosepta. Nuclear pleomorphism was mild although mitotic figures were found. Invasion of the tumour into small vascular spaces was seen at the periphery of the lesion. The chromaffin reaction of fresh tissue was negative although the argyrophil reaction was positive. Immunoperoxidase stains for neuronespecific enolase (NSE) and S100 protein showed strong staining for NSE and weaker staining for S100. Histological findings were therefore consis-tent with a malignant paraganglioma, most probably a metastasis from a retroperitoneal tumour in view of the lack of relationship of the neck mass to the carotid body.
Thin showed exclusively raised dopamine levels in 3 cases that were normotensive. '3 It was thought that the predominant or exclusive secretion of dopamine would explain the lack of hypertension due to its anti-adrenergic action that inhibits the vasoconstrictive effects of other amines. Furthermore in the same series of patients, of those that secreted dopamine (whether exclusively or together with other catecholamines) 66% were malignant compared with 30.8% of those that did not secrete dopamine. In another series of 14 patients with malignant phaeochromocytoma, Tippett et al. found increased dopamine excretion in 9 (64%) subjects including all 4 with primary intra-adrenal tumours and that this was associated with a poor prognosis.3 This is a higher proportion than in other similar studies'4 and may be due to better assessment of metastatic spread and thus the definition of malignancy by radio-pharmaceutical imaging with '3'I-meta-iodobenzylguanidine. A case of malignant chemodectoma (branchiomeric paraganglioma) has also been described with elevated urinary HVA in a patient that did not have raised blood pressure.4 Raised levels of dopamine and its metabolites may therefore be a better marker of malignancy than hitherto suspected.
The presence of raised dopamine (and its meta-bolites) may therefore reflect the lack of differentiation of tumour tissue and be a marker of malignancy as suggested in the present case. The absence of hypertension presents a further diagnostic challenge and it is important to consider this possible diagnosis in the presence of unexplained masses and to selectively test the urine for dopamine or its metabolite HVA.
